Claude Sonnet 5 agent autonomously selects a gene therapy and performs brain surgery on epileptic mice.
Gabriel Ocana-Santero, a PhD student at Oxford and co-founder of Exin Therapeutics, describes on X how the Claude Sonnet 5 agent independently selected drugs, brain regions, and injection coordinates from 19 candidate gene therapies to perform custom robotic surgery on epileptic mice. The agent made 32 observations during the procedure, and the mice recovered well.
Return to original text
A short introduction is retained here; the full text from the source website is not reposted. For specific wording and subsequent updates, please refer to the original article.
Open AIHOT original